Health care stocks were narrowly mixed this afternoon, with the NYSE Health Care Index Wednesday still rising 0.5% while the SPDR Health Care Select Sector ETF was sinking 0.3%, reversing an earlier rise. The Nasdaq Biotechnology index also was falling 0.2%. In company news, Aveo Oncology (AVEO) increased almost 6% after Wednesday saying its tivozanib drug candidate showed better results than Bayer's Nexavar in the third and fourth lines of kidney cancer based on final overall survival rates during phase III testing.
Upgrade to Premium and Analyze Stocks Like a Pro
50% Off All Subscriptions